- Home
- SLNO vs BILL Comparison
SLNO vs BILL Comparison
Compare SLNO & BILL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SLNO
- BILL
- Stock Information
- Founded
- SLNO 1999
- BILL 2006
- Country
- SLNO United States
- BILL United States
- Employees
- SLNO N/A
- BILL N/A
- Industry
- SLNO Biotechnology: Electromedical & Electrotherapeutic Apparatus
- BILL EDP Services
- Sector
- SLNO Health Care
- BILL Technology
- Exchange
- SLNO Nasdaq
- BILL Nasdaq
- Market Cap
- SLNO 3.8B
- BILL 4.3B
- IPO Year
- SLNO 2014
- BILL 2019
- Fundamental
- Price
- SLNO $79.98
- BILL $43.70
- Analyst Decision
- SLNO Strong Buy
- BILL Buy
- Analyst Count
- SLNO 9
- BILL 21
- Target Price
- SLNO $103.33
- BILL $62.89
- AVG Volume (30 Days)
- SLNO 662.7K
- BILL 2.1M
- Earning Date
- SLNO 08-06-2025
- BILL 05-08-2025
- Dividend Yield
- SLNO N/A
- BILL N/A
- EPS Growth
- SLNO N/A
- BILL N/A
- EPS
- SLNO N/A
- BILL N/A
- Revenue
- SLNO N/A
- BILL $1,422,885,000.00
- Revenue This Year
- SLNO N/A
- BILL $15.18
- Revenue Next Year
- SLNO N/A
- BILL $12.31
- P/E Ratio
- SLNO N/A
- BILL N/A
- Revenue Growth
- SLNO N/A
- BILL 14.52
- 52 Week Low
- SLNO $36.93
- BILL $36.55
- 52 Week High
- SLNO $81.54
- BILL $100.19
- Technical
- Relative Strength Index (RSI)
- SLNO 60.77
- BILL 47.49
- Support Level
- SLNO $76.14
- BILL $41.30
- Resistance Level
- SLNO $81.54
- BILL $46.33
- Average True Range (ATR)
- SLNO 2.49
- BILL 1.45
- MACD
- SLNO 0.00
- BILL -0.17
- Stochastic Oscillator
- SLNO 81.81
- BILL 48.86
About SLNO Soleno Therapeutics Inc.
Soleno Therapeutics Inc is a biopharmaceutical company developing novel therapeutics for the treatment of rare diseases. Its product candidate DCCR (Diazoxide Choline) Extended-Release tablets, is a proprietary extended-release formulation of a crystalline salt of diazoxide. DCCR has demonstrated the ability to activate the KATP channel in the brain, pancreas, and fat tissue.
About BILL BILL Holdings Inc.
BILL Holdings Inc is a provider of software-as-a-service, cloud-based payments and spend and expense management products, which allow users to automate accounts payable and accounts receivable transactions, enable businesses to easily connect with their suppliers or customers to do business, eliminate expense reports, manage cash flows and improve back office efficiency. Initial Public Offering and Follow-on Offering.